Fluticasone furoate versus fluticasone propionate for seasonal allergic rhinitis: a review of the clinical and cost-effectiveness
Canadian Agency for Drugs and Technologies in Health
Record ID 32011001021
English
Authors' recommendations:
Two randomized controlled studies showed similar efficacy between fluticasone propionate and fluticasone furoate in the management of symptoms of seasonal allergic rhinitis; no evidence on the cost-effectiveness of fluticasone furoate as compared with fluticasone propionate was identified.
Details
Project Status:
Completed
Year Published:
2011
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Anti-Allergic Agents
- Rhinitis, Allergic, Seasonal
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.